Seven, you're all about knock-offs, huh? Five Watches is being farmed like a boss? The enemy of my enemy
In fact, Zhuning'an Pharmaceutical Group had never intended to plug such a loophole. They sold HFAA purely to make money, not to deliberately disgust anyone.
Even if some people from White Eagle really were disgusting, making money off them was hardly disgusting!
They would make money no matter who they sold to, so they were not particularly picky about screening customers.
The bustling sales of HFAA by Zhuning'an Pharmaceutical Group naturally caught the attention of interested parties, including Radiance Pharmaceuticals and Aibowei Pharmaceuticals, neither of which had made Wugengtian's overseas distributor list.
The two pharmaceutical companies immediately saw through HFAA's scheme. Envious of how profitable HFAA was, they coincidentally came up with almost exactly the same idea.
Neither Radiance Pharmaceuticals nor Aibowei Pharmaceuticals was any good!
Aibowei Pharmaceuticals had even teamed up with White Eagle's FDA to secretly target Wugengtian in an attempt to suppress it.
Now that Radiance Pharmaceuticals and Aibowei Pharmaceuticals had seen HFAA sell for astronomical prices within a small area of New York, both of them independently thought of producing counterfeit HFAA!
The two pharmaceutical giants were not making counterfeit HFAA to earn huge profits, because there was no huge profit to be made. HFAA was simply too expensive for large-scale bulk shipments.
But if they only moved small quantities, it would be easy for people to determine that the counterfeit HFAA had no real therapeutic effect.
So making money from counterfeit HFAA was actually very difficult.
Given the circumstances, the two pharmaceutical giants' real goal was simply to scam people. They intended to ruin HFAA's reputation.
While Radiance Pharmaceuticals and Aibowei Pharmaceuticals were preparing to stir up trouble, Johnson Pharmaceuticals and Dongmosha Pharmaceuticals were also preparing to imitate HFAA and make their move.
These two overseas distributors of Wugengtian Pharmaceutical Group were both considering one